VKTX Viking Therapeutics, Inc.

HealthcareBiotechnology
$31.58
▼ 2.17%
36
QScore Signal
Short
Confidence: MEDIUM
Long-Term
28
Short-Term
43

Value

29
P/E-7.73
8
P/B7.27
43
P/S0.00
70
EV/EBITDA-7.07
5

Growth

26
Revenue Growth0.0%
28
EPS Growth-215.8%
28
FCF Growth-217.4%
20

Momentum

64
12-Month Return16.9%
59
3-Month Return20.1%
92
1-Month Return-6.2%
42
RSI (14)33.72
50
50/200 MABullish
75

Profitability

18
ROE-71.3%
38
ROA-77.7%
0
Gross Margin0.0%
14
Operating Margin0.0%
21
Net Margin0.0%
26
FCF Yield-9.3%
0

Risk

34
Beta0.71
75
60-Day Volatility56.0%
0

Generated 5/7/2026, 10:04:21 PM · How is this calculated?

QScore Analysis